Paracetamol News and Research

RSS

Paracetamol is a drug that reduces pain and fever (but not inflammation). It belongs to the family of drugs called analgesics.

Are NSAIDS enough for cancer pain?

Non-steroidal anti-inflammatory drugs (NSAIDs) are effective in managing cancer pain with few side effects, according to a new review of a number of studies.

24 Jan 2005

Magnetic bracelets reduce pain in osteoarthritis of the hip and knee

Osteoarthritis affects around 760,000 people in the United Kingdom, producing over 3 million general practice consultations in 2000. Manufacturers of magnetic bracelets claim that they can reduce pain and worldwide sales were estimated at £2.6bn ($5bn) in 1999. But evidence about their effectiveness is contradictory.

20 Dec 2004

Selling paracetamol and other painkillers in smaller pack sizes has slashed rates of suicide

Selling paracetamol and other painkillers in smaller pack sizes has slashed rates of suicide and damage to the liver from paracetamol poisoning, concludes a study on bmj.com this week.

29 Oct 2004

Cost cutting measures and patent expirations to propel the European generics and biogenerics market

The upcoming spate of patent expirations bodes well for the European generics market. The growing loss of patent protection on blockbuster brands over the next few years, coupled with the rising need to contain spiralling healthcare costs, is set to provide a fillip to market expansion.

19 Oct 2004

Eight out of ten women take some form of therapeutic drugs during pregnancy

The advice from the British National Formulary (British Medical Association and the Royal Pharmaceutical Society of Great Britain) is that all drugs should be avoided if possible during the first three months – and only prescribed at all if the benefits to the mother outweigh the risk to the foetus.

6 Oct 2004

Data demonstrate that Celebrex does not increase the risk of heart attack or stroke in patients with arthritis and pain

Pfizer has said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.

4 Oct 2004

Request for further evidence about the risks and benefits of the painkiller co-proxamol

The MHRA today issued a request for any further evidence about the risks and benefits of the painkiller co-proxamol, as part of an ongoing review being carried out by Committee on the Safety of Medicines (CSM).

30 Jun 2004